Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Beneficial effects of starting oral cysteamine treatment in the first 2 months of life on glomerular and tubular kidney function in infantile nephropathic cystinosis

Molecular Genetics and Metabolism(2022)10.1016/j.ymgme.2022.06.009Source: DataRank Database

Beneficial effects of starting oral cysteamine treatment in the first 2 months of life on glomerular and tubular kidney function in infantile nephropathic cystinosis is a research paper published in Molecular Genetics and Metabolism (2022). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access19 citations

Download PDF

Cite:

Linked data & code

omim

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 2.20)OA: hybridTopics (24)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Christina Nießl,Dieter Haffner ORCID,Jun Oh ORCID,Christine Okorn,Katja Palm ORCID

Live enrichment

PubMed:35843134 PMC:PMC9413354 OpenAlex:https://openalex.org/W4283769686

Intramural NIH HHS

Grant: Z01 HG000215

Cystinosis Foundation

National Human Genome Research Institute

NIH

FWCI

2.20

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://www.sciencedirect.com/science/article/pii/S1096719222003584/pdf

publisherhttps://www.sciencedirect.com/science/article/pii/S1096719222003584/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1096719222003584?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1096719222003584?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ymgme.2022.06.009

Fields of Study

Biomedical Research and PathophysiologyNeonatal Health and BiochemistryMethemoglobinemia and Tumor Lysis Syndrome

MeSH Terms

CysteamineCystineCystinosisFanconi SyndromeHumansInfantInfant, NewbornKidney

Keywords

CystinosisCysteamineFanconi syndromeCystineRenal functionMedicineInternal medicineEndocrinologyKidneyChemistryBiochemistryTubular FunctionGlomerular Function

Sustainable Development Goals

SDG 0: Good health and well-being

Beneficial effects of starting oral cysteamine treatment in the first 2 months of life on glomerular and tubular kidney function in infantile nephropathic cystinosis

FAIR Checklist

Authors (9)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)